Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)
IBRX logo

IBRX

NGS
ImmunityBio Inc.
ManufacturingBiological Product (except Diagnostic) Manufacturing
Watchlists:
Last updated: Monday 14th July 2025
2.81
-0.06 (-2.09%)
Prev Close:2.87
Open:2.88
Bid:2.8
Ask:2.83
52 Week Range
1.83
7.48
Volume:8,794,517
Mkt Cap:2,392 M
Price Target
$3.23
+14.9%
Metrics

Growth

EPS
QoQ
N/A
YoY
N/A
Revenue
QoQ
N/A
YoY
N/A
Free Cash Flow
QoQ
N/A
YoY
N/A

Peers

Peers data not available
Available data keys: fn_01356, peerValues

Risk

Financial Health

Liquidity Ratios
Financial Scores

Technicals

Technical Oscillators
Volatility Metrics
Financials

Financial Statements

IBRX - Income Statement (Annual)

Dec-24Dec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17Dec-16Dec-15
Commission Expenses-100000.0-36000.0
Depreciation And Amortization16 M17 M16 M14 M13 M8 M-7 M-3 M-1000000.0-100000.0
Earnings From Equity Interest-8 M-12 M-803000.0
Earnings From Equity Interest Net Of Tax-8 M-12 M-803000.0
Gain On Sale Of Security21 M1 M-3 M-4 M2 M2 M3000.052000.0190000.03 M
General And Administrative Expense169 M130 M103 M135 M71 M18 M-3 M-3 M-3 M-1 M
Gross Profit Margin (profit Margin After CGS)15 M622000.0240000.0934000.0605000.043000.047000.045000.044000.0236000.0
Interest Expense Non Operating115 M129 M64 M15 M9 M19000.0433000.0618000.066000.0
Interest Expense Operating-35 M-2 M
Minority Interests81000.0656000.0753000.03 M2 M
Misc Other Special Charges20 M-50 M13 M193000.01 M298000.0236000.0157000.088000.0-1 M
Net Income (loss)-414 M-583 M-417 M-347 M-222 M-66 M-96 M-96 M-121 M-237 M
Net Income Common Stockholders-414 M-418 M-417 M-347 M-222 M-66 M-96 M-96 M-121 M-237 M
Net Income Continuous Operations-414 M-418 M-417 M-347 M-222 M-66 M-96 M-96 M-121 M-237 M
Net Non Operating Interest Income Expense-112 M-128 M61 M-15 M-9 M-19000.01 M2 M3 M3 M
Non Recurring Operation Expense-12 M
Normalized Income-410 M
Operating Income-344 M-362 M-351 M-330 M-221 M-68 M-98 M-99 M-124 M-239 M
Operating Income Before Depreciation (EBITDA)-142 M-223 M-313 M-321 M-204 M-57 M-86 M-89 M-116 M-236 M
Operating Expense359 M363 M351 M331 M221 M68 M-98 M-99 M-125 M-239 M
Other Gand A169 M130 M103 M135 M71 M18 M-3 M-3 M-3 M-1 M
Other Impairment Of Capital Assets886000.0681000.011 M
Other Operating Expenses-1 M-19 M-2 M-536000.0-5 M-4 M-98 M-99 M-125 M-239 M
Rent And Landing Fees-3 M-3 M-3 M-1 M
Research Expense190 M232 M248 M196 M140 M50 M56 M42 M29 M11 M
Restructring And Mn A Income-1000000.0
Salaries And Wages34 M49 M40 M-23 M-37 M-74 M-211 M
Selling And Marketing Expense43 M57 M95 M228 M
Selling Expense43 M57 M95 M228 M
Total Income Available For Interest Expense (EBIT)-188 M-290 M-354 M-337 M-217 M-66 M-96 M-96 M-121 M-237 M
Total Revenues15 M622000.0240000.0934000.0605000.043000.047000.045000.044000.0236000.0
Total Expenses359 M363 M351 M331 M221 M68 M-98 M-99 M-125 M-239 M
Total Revenue15 M622000.0240000.0934000.0605000.043000.047000.045000.044000.0236000.0
Amord2 M2 M20 M1 M600000.0-2 M-2 M-3 M-1 M
Avgshs697 M509 M400 M389 M104 M94 M79 M81 M82 M72 M
Avgshsdt700 M509 M400 M389 M104 M94 M79 M80 M82 M72 M
Basiceps-0.59-1.15-1.04-0.89-0.89-0.7
Basicepscont-0.59-1.15-1.04-0.89-0.89-0.7
Depamor16 M17 M16 M14 M13 M8 M-7 M-3 M-1000000.0-100000.0
Dileps-0.62-1.15-1.04-0.89-0.89-0.7-1.22-1.2-1.47-3.31
Dilepscont-0.62-1.15-1.04-0.89
Intinc2 M863000.03 M836000.02 M2 M2 M4 M5 M312000.0
Netincdisc-414 M-583 M-417 M-347 M-222 M-66 M-96 M-96 M-121 M-237 M
Othincexp-41 M57 M-6 M5 M7 M-2 M-236000.0-157000.0-88000.01 M
Pretaxinc-414 M-584 M-417 M-350 M-226 M-66 M-97 M-97 M-121 M-237 M
Resdev190 M232 M248 M196 M140 M50 M56 M42 M29 M11 M
Restruct-1000000.0
Sga169 M130 M103 M135 M71 M18 M43 M57 M95 M228 M
Shsout853 M674 M436 M398 M109 M98 M79 M79 M82 M82 M
Specincchg1000000.012 M
Taxprov-40000.034000.09000.0-2 M-97000.0-503000.0-493000.0-572000.0-301000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader